CN Patent

CN111302963A — 一种制备3-氨甲基-5-甲基己酸的方法

Assigned to Hefei Amvite Pharmaceutical Co ltd · Expires 2020-06-19 · 6y expired

What this patent protects

本发明涉及一种制备3‑氨甲基‑5‑甲基己酸的方法，属于化学技术领域。本发明以3‑甲酸甲酯‑5‑甲基己酸为原料，经氨酯交换和还原2步反应即可制得目标产物。其有益效果是：工艺路线简洁、产品纯度高99.0％以上、三废少、无有毒化剂、反应条件温和、成本低廉，适用于工业化生产。

USPTO Abstract

本发明涉及一种制备3‑氨甲基‑5‑甲基己酸的方法，属于化学技术领域。本发明以3‑甲酸甲酯‑5‑甲基己酸为原料，经氨酯交换和还原2步反应即可制得目标产物。其有益效果是：工艺路线简洁、产品纯度高99.0％以上、三废少、无有毒化剂、反应条件温和、成本低廉，适用于工业化生产。

Drugs covered by this patent

indigotindisulfonate-sodium (INDIGOTINDISULFONATE SODIUM)

Patent Metadata

Patent number: CN111302963A
Jurisdiction: CN
Classification: —
Expires: 2020-06-19
Drug substance claim: No
Drug product claim: No
Assignee: Hefei Amvite Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.